Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
57
ORMP Quote, Financials, Valuation and Earnings
Last price:
$3.17
Seasonality move
:
22.27%
Day range:
$2.99 - $3.24
52-week range:
$1.82 - $3.24
Dividend yield:
0%
P/E ratio:
3.14x
P/S ratio:
65.57x
P/B ratio:
0.62x
Volume:
277.4K
Avg. volume:
227.2K
1-year change:
32.35%
Market cap:
$125.4M
Revenue:
--
EPS (TTM):
$1.00
Earnings Data
Next earnings date for ORMP
Mar 31
2026
Most recent earnings per share
$1.13
Beat by $1.13
(Nov 13/2025)
Consensus Estimate
--
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORMP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 | -- | -- | -- | -- | -- |
| 11/13/2025 | Q3 | -- | -- | $1.13 | -- | -- |
| 08/14/2025 | Q2 | -- | -- | $0.31 | -- | -- |
| 04/28/2025 | Q1 | -- | $2M | -$0.19 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$0.26 | -- | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.48 | -$0.02 | -$0.46 |
| 08/14/2024 | Q2 | $250K | -- | $0.22 | -$0.02 | $0.24 |
| 05/09/2024 | Q1 | $500K | -- | $0.04 | $0.02 | $0.02 |
| 12/31/2023 | Q4 | -- | -- | $0.33 | -$0.01 | $0.34 |
| 11/09/2023 | Q3 | $700K | -- | -$0.08 | -$0.09 | $0.01 |
| 08/10/2023 | Q2 | -- | $674K | -$0.03 | -- | -- |
| 05/11/2023 | Q1 | -- | $666K | -$0.08 | -- | -- |
| 12/31/2022 | Q4 | -- | $681K | -$0.22 | -- | -- |
| 11/10/2022 | Q3 | -- | $682K | -$0.18 | -- | -- |
| 08/10/2022 | Q2 | -- | $674K | -$0.27 | -- | -- |
| 08/10/2022 | Q2 | -- | -- | -- | -$0.25 | -- |
| 05/12/2022 | Q1 | -- | $666K | -$0.27 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -- | -$0.23 | -- |
| 01/11/2022 | Q4 | -- | $674K | -$0.22 | -- | -- |
| 08/31/2021 | Q3 | -- | $683K | -$0.21 | -- | -- |
| 07/14/2021 | Q2 | -- | $681K | -$0.17 | -- | -- |
| 04/13/2021 | Q1 | -- | $665K | -$0.17 | -- | -- |
| 01/14/2021 | Q4 | -- | $674K | -$0.23 | -- | -- |
| 08/31/2020 | Q3 | -- | $681K | -$0.13 | -- | -- |
| 07/07/2020 | Q2 | -- | $681K | -$0.10 | -- | -- |
| 04/06/2020 | Q1 | -- | $674K | -$0.21 | -- | -- |
| 01/09/2020 | Q4 | -- | $674K | -$0.15 | -- | -- |
| 08/31/2019 | Q3 | -- | $681K | -$0.13 | -- | -- |
| 07/10/2019 | Q2 | -- | $682K | -$0.23 | -- | -- |
| 04/10/2019 | Q1 | -- | $666K | -$0.21 | -- | -- |
| 01/14/2019 | Q4 | -- | $674K | -$0.25 | -- | -- |
| 08/31/2018 | Q3 | -- | $617K | -$0.18 | -- | -- |
| 07/12/2018 | Q2 | -- | $617K | -$0.30 | -- | -- |
| 02/28/2018 | Q1 | -- | $604K | -$0.20 | -- | -- |
| 11/30/2017 | Q4 | -- | $611K | -$0.18 | -- | -- |
| 08/31/2017 | Q3 | -- | $618K | -$0.20 | -- | -- |
| 05/31/2017 | Q2 | -- | $617K | -$0.15 | -- | -- |
| 04/05/2017 | Q1 | -- | $611K | -$0.24 | -- | -- |
| 01/11/2017 | Q4 | -- | $610K | -$0.20 | -- | -- |
| 11/30/2016 | Q3 | -- | $353K | -$0.36 | -- | -- |
| 07/06/2016 | Q2 | -- | $163K | -$0.15 | -- | -- |
| 04/08/2016 | Q1 | -- | $125K | -$0.14 | -- | -- |
Oramed Pharmaceuticals, Inc. Earnings Questions
-
How Much did Oramed Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Oramed Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Oramed Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Oramed Pharmaceuticals, Inc. announced earnings per share of $1.13 which represents a beat of analyst forecast a -- per share.
-
Is Oramed Pharmaceuticals, Inc. Profitable?
Oramed Pharmaceuticals, Inc. reported -$31K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Oramed Pharmaceuticals, Inc. EPS Next Year?
Oramed Pharmaceuticals, Inc.'s earnings are forecast to grow from -$0.47 per share to $0.17 per share next year representing an increase of 21.43%.
-
When is Oramed Pharmaceuticals, Inc.'s Earnings Date?
Oramed Pharmaceuticals, Inc.'s next earnings date is March 31, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.29% over the past day.
Buy
68
KOD alert for Dec 26
Kodiak Sciences, Inc. [KOD] is down 5.28% over the past day.
Buy
64
ZCSH alert for Dec 23
Grayscale Zcash Trust (ZEC) [ZCSH] is down 0% over the past day.
